Clinical Trials · NCT05369013

Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.

Name: Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownN/ATeriparatide

Phase: N/A
Recruitment status: Unknown
Sponsor: STADA, Spain
Enrollment: 188
Start date: Jun 2021
Locations: 10 sites, Spain
Primary endpoint: Effectiveness for patients treatment with original

View Teriparatide compound reference